Recursion Pharmaceuticals, Inc. (RXRX) intrinsic value

Price $4.78 on 2026-10-06.

MethodValueMargin of safety
DCF – bear case$0.41
DCF – base case$0.53-88.8%
DCF – bull case$0.64
Graham Number——

WACC 10.0%, revenue growth -60.1%, FCF margin -400.1%, EPS -$1.00, book value per share $1.71. 1 valuation runs recorded.

Community analyses of RXRX

More valuations

Run your own DCF · How accurate are these valuations?